In the sorafenib-resistant HCC cell line we established, expression of Nrf2 and HO-1 were robustly increased compared with the parental cell line, which suggests an important role for the Nrf2 signaling pathway in sorafenib-resistant HCC. Here, NFE2L2 is linked to hepatocellular carcinoma.